# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-23-000051
Filing Date
2023-07-31
Accepted
2023-07-31 08:47:17
Documents
7
Period of Report
2023-07-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | form6-kxpressreleasecoverf.htm | 6-K | 20372
2 | EX-99.1 | exhibit991-appendix4c.htm | EX-99.1 | 23802
3 |  | exhibit991-appendix4c001.jpg | GRAPHIC | 519449
4 |  | exhibit991-appendix4c002.jpg | GRAPHIC | 265807
5 |  | exhibit991-appendix4c003.jpg | GRAPHIC | 215095
6 |  | exhibit991-appendix4c004.jpg | GRAPHIC | 388030
7 |  | exhibit991-appendix4c005.jpg | GRAPHIC | 118751
| Complete submission text file | 0001345099-23-000051.txt |  | 2121190

Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 231125176
SIC: 2836 Biological Products, (No Diagnostic Substances)